Skip to main content

Facioscapulohumeral Muscular Dystrophy clinical trials at UCSD

1 research study open to eligible people

Showing trials for
  • AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)

    open to eligible people ages 18-65

    A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Adult Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

    San Diego, California and other locations

Last updated: